KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Cash & Current Investments: 2016-2025

Historic Cash & Current Investments for Moderna (MRNA) over the last 8 years, with Sep 2025 value amounting to $4.5 billion.

  • Moderna's Cash & Current Investments fell 34.41% to $4.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $22.6 billion, marking a year-over-year decrease of 30.32%. This contributed to the annual value of $7.0 billion for FY2024, which is 18.35% down from last year.
  • According to the latest figures from Q3 2025, Moderna's Cash & Current Investments is $4.5 billion, which was down 12.22% from $5.1 billion recorded in Q2 2025.
  • Moderna's Cash & Current Investments' 5-year high stood at $10.7 billion during Q4 2021, with a 5-year trough of $4.5 billion in Q3 2025.
  • Moreover, its 3-year median value for Cash & Current Investments was $7.6 billion (2023), whereas its average is $7.3 billion.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first skyrocketed by 535.07% in 2021, then tumbled by 39.55% in 2025.
  • Over the past 5 years, Moderna's Cash & Current Investments (Quarterly) stood at $10.7 billion in 2021, then declined by 7.69% to $9.9 billion in 2022, then fell by 13.11% to $8.6 billion in 2023, then dropped by 18.35% to $7.0 billion in 2024, then tumbled by 34.41% to $4.5 billion in 2025.
  • Its Cash & Current Investments stands at $4.5 billion for Q3 2025, versus $5.1 billion for Q2 2025 and $6.0 billion for Q1 2025.